File Browser

ABBOTT LABORATORIES, LIMITED ET AL v. THE MINISTER OF HEALTH ET AL

Summary of T-1451-11

The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.

Federal Court Type: S. 18.1 Patented Medicines (Notice of Compliance) Regulations

Parties and Lawyers:
PartyFirmLawyer
ABBOTT LABORATORIES LTDMcCarthy Tétrault LLPREDDON, ANDREW J
MINISTER OF HEALTH (THE)
MYLAN PHARMACEUTICALS ULC
TAKEDA PHARMACEUTICAL COMPANY LTD
TAKEDA PHARMACEUTICALS AMERICA INC
Intellectual Property:
NameNumber
1338377
2338792
2323680

Patented Medicine: Lansoprazole (Medicinal ingredients are based on automated analysis and should not be relied upon.)

Docket Summary (Google Translate to English)

(20) 2013-01-18 - Toronto
Affidavit of service of DALE KENNEDY sworn on 18-JAN-2013 on behalf of Applicant confirming service of DOC 19 upon RESPONDENTS all parties by telecopier on 18-JAN-2013 filed on 18-JAN-2013
(19) 2013-01-18 - Toronto
Discontinuance on behalf of Applicant with consent on behalf of all parties filed on 18-JAN-2013
(18) 2013-01-18 - Toronto
Consent on behalf of Applicant to DISCONTINUANCE filed on 18-JAN-2013
() 2012-09-04 - Toronto
Communication to the Court from the Registry dated 04-SEP-2012 re: 4-SEP-2012 draft order on consent to amend sent to the court for consideration
() 2012-09-04 - Toronto
Letter from Applicant dated 04-SEP-2012 providing the court with a draft order on consent to amend the 16-NOV-2012 scheduling order of Prothonotary Aalto received on 04-SEP-2012
() 2012-09-13 - Toronto
Acknowledgment of Receipt received from the parties by email as per standing agreement with respect to doc.17 placed on file on 13-SEP-2012
(17) 2012-09-12 - Toronto
Order dated 12-SEP-2012 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Order dated 16-NOV-2011 Result: The scheduling of this proceeding shall continue as follows with amendment as necessary to the Scheduling Order of Prothonotary Kevin R. Aalto dated November 16, 2011: (a)Cross-examinations shall be completed no later than November 16, 2012; (b) The Applicants' and Takeda Pharmaceutical Company Limited's application records shall be served and filed no later than January 21, 2013; (c)_The Respondent Mylan Pharmaceuticals ULC's responding application records shall be served and filed no later than March 21, 2013 Filed on 12-SEP-2012 copies sent to parties entered in J. & O. Book, volume 1168 page(s) 148 - 149 Interlocutory Decision
() 2012-06-08 - Ottawa
Acknowledgment of Receipt received from all parties with respect to Order (time and place)(Doc. No. 16). placed on file on 08-JUN-2012
(16) 2012-06-08 - Ottawa
Order (time and place) dated 08-JUN-2012 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Toronto on 21-MAY-2013 to begin at 09:30 duration: 4d language: E Filed on 08-JUN-2012 cc's sent to parties entered in J. & O. Book, volume 1160 page(s) 74 - 74 Transmittal letters placed on file
(15) 2012-05-31 - Toronto
Solicitor's certificate of service on behalf of Fiona Legere confirming service of DOC 14 upon all parties by telecopier on 31-MAY-2012 filed on 31-MAY-2012
(14) 2012-05-31 - Toronto
Requisition for hearing - Application from Applicant filed on 31-MAY-2012 Tariff Application or appeal - $50.00
() 2012-01-11 - Toronto
Acknowledgment of Receipt received from all parties with respect to doc. 13 received by fax placed on file on 11-JAN-2012
(13) 2012-01-11 - Toronto
Order dated 11-JAN-2012 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 29-DEC-2011 re: Draft Disclosure, Verification and Protective Order on consent Result: granted Filed on 11-JAN-2012 certified copies sent to parties entered in J. & O. Book, volume 1145 page(s) 353 - 363 Interlocutory Decision
() 2011-12-29 - Toronto
Letter from Applicant dated 29-DEC-2011 providing the court with a draft Protective Order on consent received on 29-DEC-2011
() 2011-11-16 - Toronto
Acknowledgment of Receipt received from all parties with respect to doc. 12 received by fax placed on file on 16-NOV-2011
(12) 2011-11-16 - Toronto
Order dated 16-NOV-2011 rendered by Kevin Aalto, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1)The evidence of Abbot Laboratories Limited, Takeda Pharmaceuticals America Inc., (collectively, the "Applicants") and Takeda Pharmaceutial Company Company Limited (¿TPC¿) regarding patent and claim construction, infringement, as well as any factual evidence the aforesaid parties intend to rely upon to support the validity of the patents, including evidence from the inventors of the patents, and any factual evidence relating to the embodiment of the patent claims in the PREVACID FASTAB¿ formulation, shall be served (not filed) no later than February 15, 2012. For further clarity, paragraph shall not be interpreted to preclude the Applicants and TCP from serving evidence on July 15, 2012 regarding patent and claims construction as it pertains to validity; 2)The Applicant shall advis the Respondents and Respondent/Patentee in writing of which claims of which patents they do not intend to assert in this proceeding no later than February 15, 2012; 3)The Respondent's, Mylan Pharmaceuticals ULC ("Mylan"), evidince shall be served (not filed) no later than May 15, 2012; 4)The Applicants shall serve and file a requistion for hearing no later than May 31, 2012; 5)The Applicants' and TPC's evidence regarding invalidity shall be served (not filed) no later than July 16, 2012; 6)Any advisory letter as to whether a Rule 312 or section 6(5) motion pursuant the PMNOC Regulations will be served and request for case management conference (if a motion is to be brought), will be sent no later than July 31, 2012... Filed on 16-NOV-2011 certified copies sent to parties entered in J. & O. Book, volume 1141 page(s) 259 - 262 Interlocutory Decision
() 2011-11-14 - Toronto
Toronto 14-NOV-2011 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the court will speak to the hearings coordinator to arrange a 5 day hearing for sometime in April 2013. held in chambers by way of Conference Call Duration per day: 14-NOV-2011 from 02:05 to 02:15 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 10min Appearances: Mr. Tait 416-601-7717 representing Applicant Abbott Laboratories Ltd. Mr. Van Barr 1-613-786-8675 representing Respondent Patentee, Tekeda Pharmaceutical Company Limited Mr. de Grandpré 416-862-6570 representing Respondent Mylan Pharmaceuticals ULC Minutes of Hearing entered in Vol. 852 page(s) 373 - 374 Abstract of Hearing placed on file
() 2011-11-09 - Toronto
Letter from Applicant dated 09-NOV-2011 adjourning the Motion scheduled for 14-NOV-2011 and requesting a CMC in its place received on 09-NOV-2011
() 2011-10-24 - Toronto
Toronto 24-OCT-2011 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the Motions for Reversal of Evidence and Productions has been scheduled for 14-NOV-2011 at 10:00 a.m. for a duration of 3 hours held in chambers by way of Conference Call Duration per day: 24-OCT-2011 from 03:10 to 03:30 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 20min Appearances: Mr. Tait 416-601-7717 representing Applicant Mr. Van Barr 1-613-786-8675 representing Defendant Mr. Norrie 416-862-6570 representing Defendant Minutes of Hearing entered in Vol. 851 page(s) 298 - 299 Abstract of Hearing placed on file
() 2011-10-17 - Toronto
Oral directions received from the Court: Kevin Aalto, Prothonotary dated 17-OCT-2011 directing that The parties are granted a 7 day extension to reach a joint timetable placed on file on 17-OCT-2011
() 2011-10-14 - Toronto
Communication to the Court from the Registry dated 14-OCT-2011 re: Letter from the Applicant dated 14-Oct-2011 sent to Court for consideration
() 2011-10-14 - Toronto
Letter from Applicant dated 14-OCT-2011 requesting an additional 7 days to reach a joint timetable received on 14-OCT-2011
() 2011-10-04 - Toronto
Oral directions received from the Court: Kevin Aalto, Prothonotary dated 04-OCT-2011 directing that the parties shall, within ten days of the date of this direction, file a joint proposal for a timetable to govern the steps in this proceeding, and incorporating into the timetable, any motions that could be contemplated, including any motions relating to protective or confidentiality orders, production pursuant to ss. 6(7) of the PMNOC Regulations, verification orders, leave to file additional affidavits pursuant to Rule 312 of the Federal Courts Rules or motions pursuant to ss.6(5) of the PMNOC Regulations . The timetable shall address the order of evidence to be served and filed and shall also incorporate dates by which the parties shall file their records, the requisition for hearing and the dates by which parties shall confirm by letter, whether or not any of the contemplated motions will be brought, which letter shall include dates for a case management teleconference to be conducted prior to any motion being filed. In the event the parties cannot agree to a timetable each shall, within the ten days, file an independent proposal and dates of mutual availability for a case management teleconference placed on file on 04-OCT-2011 Confirmed in writing to the party(ies)
() 2011-09-22 - Ottawa
Acknowledgment of Receipt received from all parties (by E-MAIL) with respect to the Order of the Court dated 20-SEP-2011 placed on file on 22-SEP-2011
() 2011-09-21 - Ottawa
Covering letter from Respondent, Mylan Pharmaceuticals ULC, dated 21-SEP-2011 concerning Doc. Nos. 10 11 placed on file on 21-SEP-2011
(11) 2011-09-21 - Ottawa
Solicitor's certificate of service on behalf of J. Bradley White confirming service of Doc. No. 10 upon Applicant by telecopier on 21-SEP-2011 filed on 21-SEP-2011
(10) 2011-09-21 - Ottawa
Notice of appearance on behalf of Respondent, Mylan Pharmaceuticals ULC, filed on 21-SEP-2011
(9) 2011-09-21 - Toronto
Affidavit of service of Leo Pereira sworn on 19-SEP-2011 on behalf of Applicants confirming service of Doc.1 upon Respondent - Mylan Pharmaceuticals ULC by personal service on 15-SEP-2011 filed on 21-SEP-2011
(8) 2011-09-21 - Toronto
Service copy of Doc. No. 1 with proof of service upon Respondent - Takeda Pharmaceutical Company Limited on 15-SEP-2011 filed on 21-SEP-2011
() 2011-09-21 - Ottawa
Acknowledgment of Receipt received from the Applicants, the Respondent (Minister of Health) and the Respondent with respect to Patentee placed on file on 21-SEP-2011
(7) 2011-09-20 - Ottawa
Order dated 20-SEP-2011 rendered by Acting Chief Justice S Noël Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: pursuant to R. 383 assigning Prothonotary Aalto as CMJ Filed on 20-SEP-2011 copies sent to parties entered in J. & O. Book, volume 1134 page(s) 439 - 439 Interlocutory Decision
(6) 2011-09-13 - Ottawa
Affidavit of service of Adam Lim sworn on 13-SEP-2011 on behalf of Respondent Patentee confirming service of Notice of Appearance upon Applicant by telecopier on 13-SEP-2011 confirming service Notice of Appearance upon Respondent by telecopier on 13-SEP-2011 filed on 13-SEP-2011
(5) 2011-09-13 - Ottawa
Notice of appearance on behalf of Respondent Patentee filed on 13-SEP-2011
(4) 2011-09-13 - Toronto
Affidavit of service of James Adeney sworn on 13-SEP-2011 on behalf of Respondent confirming service of Doc 3 upon all parties by telecopier on 12-SEP-2011 with Exhibits A filed on 13-SEP-2011
(3) 2011-09-13 - Toronto
Notice of appearance on behalf of Respondent filed on 13-SEP-2011
(2) 2011-09-09 - Toronto
Service copy of Notice of Application with proof of service upon Respondent on 08-SEP-2011 filed on 09-SEP-2011
(1) 2011-09-07 - Toronto
Notice of application with regard to Intellectual Property filed on 07-SEP-2011 Tariff fee of $50.00 received: yes

The official version of the court proceeding information is available from the court websites directly:
Browse another proceeding. Enter Court File No:

Canadian Intellectual Property